BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 29216889)

  • 21. Cross-talk between fMLP and vitronectin receptors triggered by urokinase receptor-derived SRSRY peptide.
    Gargiulo L; Longanesi-Cattani I; Bifulco K; Franco P; Raiola R; Campiglia P; Grieco P; Peluso G; Stoppelli MP; Carriero MV
    J Biol Chem; 2005 Jul; 280(26):25225-32. PubMed ID: 15866865
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Participation of the urokinase-type plasminogen activator receptor (uPAR) in neutrophil transendothelial migration.
    Pliyev BK; Antonova OA; Menshikov M
    Mol Immunol; 2011 May; 48(9-10):1168-77. PubMed ID: 21470685
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of urokinase plasminogen activator receptor in thrombospondin 1-mediated tumor cell invasion.
    Albo D; Berger DH; Rothman VL; Tuszynski GP
    J Surg Res; 1999 Apr; 82(2):331-8. PubMed ID: 10090848
    [TBL] [Abstract][Full Text] [Related]  

  • 24. RNAi-mediated downregulation of urokinase plasminogen activator receptor inhibits proliferation, adhesion, migration and invasion in oral cancer cells.
    Liang X; Yang X; Tang Y; Zhou H; Liu X; Xiao L; Gao J; Mao Z
    Oral Oncol; 2008 Dec; 44(12):1172-80. PubMed ID: 18486529
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SPARC-induced migration of glioblastoma cell lines via uPA-uPAR signaling and activation of small GTPase RhoA.
    Kunigal S; Gondi CS; Gujrati M; Lakka SS; Dinh DH; Olivero WC; Rao JS
    Int J Oncol; 2006 Dec; 29(6):1349-57. PubMed ID: 17088972
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overexpression of urokinase receptor increases matrix invasion without altering cell migration in a human osteosarcoma cell line.
    Karikó K; Kuo A; Boyd D; Okada SS; Cines DB; Barnathan ES
    Cancer Res; 1993 Jul; 53(13):3109-17. PubMed ID: 8391387
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Coordinated expression of the vitronectin receptor and the urokinase-type plasminogen activator receptor in metastatic melanoma cells.
    Nip J; Rabbani SA; Shibata HR; Brodt P
    J Clin Invest; 1995 May; 95(5):2096-103. PubMed ID: 7537755
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Urokinase-type plasminogen activator binding to its receptor stimulates tumor cell migration by enhancing integrin-mediated signal transduction.
    Yebra M; Goretzki L; Pfeifer M; Mueller BM
    Exp Cell Res; 1999 Jul; 250(1):231-40. PubMed ID: 10388537
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The formyl peptide receptor 1 exerts a tumor suppressor function in human gastric cancer by inhibiting angiogenesis.
    Prevete N; Liotti F; Visciano C; Marone G; Melillo RM; de Paulis A
    Oncogene; 2015 Jul; 34(29):3826-38. PubMed ID: 25263443
    [TBL] [Abstract][Full Text] [Related]  

  • 30. uPA/uPAR system activation drives a glycolytic phenotype in melanoma cells.
    Laurenzana A; Chillà A; Luciani C; Peppicelli S; Biagioni A; Bianchini F; Tenedini E; Torre E; Mocali A; Calorini L; Margheri F; Fibbi G; Del Rosso M
    Int J Cancer; 2017 Sep; 141(6):1190-1200. PubMed ID: 28577299
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Mechanisms of Participation of the Urokinase Receptor in Directed Axonal Growth].
    Klimovich PS; Semina EV
    Mol Biol (Mosk); 2020; 54(1):103-113. PubMed ID: 32163394
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Expression of Formyl Peptide Receptor 1 is Correlated with Tumor Invasion of Human Colorectal Cancer.
    Li SQ; Su N; Gong P; Zhang HB; Liu J; Wang D; Sun YP; Zhang Y; Qian F; Zhao B; Yu Y; Ye RD
    Sci Rep; 2017 Jul; 7(1):5918. PubMed ID: 28724995
    [TBL] [Abstract][Full Text] [Related]  

  • 33. siRNA-mediated simultaneous downregulation of uPA and its receptor inhibits angiogenesis and invasiveness triggering apoptosis in breast cancer cells.
    Subramanian R; Gondi CS; Lakka SS; Jutla A; Rao JS
    Int J Oncol; 2006 Apr; 28(4):831-9. PubMed ID: 16525631
    [TBL] [Abstract][Full Text] [Related]  

  • 34. cDNA transfection of amino-terminal fragment of urokinase efficiently inhibits cancer cell invasion and metastasis.
    Zhu F; Jia S; Xing G; Gao L; Zhang L; He F
    DNA Cell Biol; 2001 May; 20(5):297-305. PubMed ID: 11410166
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of formic receptors in soluble urokinase receptor-induced human vascular smooth muscle migration.
    Duru EA; Fu Y; Davies MG
    J Surg Res; 2015 May; 195(2):396-405. PubMed ID: 25758338
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cleavage of the urokinase receptor (uPAR) on oral cancer cells: regulation by transforming growth factor - β1 (TGF-β1) and potential effects on migration and invasion.
    Magnussen SN; Hadler-Olsen E; Costea DE; Berg E; Jacobsen CC; Mortensen B; Salo T; Martinez-Zubiaurre I; Winberg JO; Uhlin-Hansen L; Svineng G
    BMC Cancer; 2017 May; 17(1):350. PubMed ID: 28526008
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.
    Hildenbrand R; Schaaf A
    Int J Oncol; 2009 Jan; 34(1):15-23. PubMed ID: 19082473
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of urokinase-type plasminogen activator receptor induces apoptosis in melanoma cells by activation of p53.
    Besch R; Berking C; Kammerbauer C; Degitz K
    Cell Death Differ; 2007 Apr; 14(4):818-29. PubMed ID: 17110957
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Urokinase and urokinase receptor participate in regulation of neuronal migration, axon growth and branching.
    Semina E; Rubina K; Sysoeva V; Rysenkova K; Klimovich P; Plekhanova O; Tkachuk V
    Eur J Cell Biol; 2016 Sep; 95(9):295-310. PubMed ID: 27324124
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New Pieces in the Puzzle of uPAR Role in Cell Migration Mechanisms.
    Gorrasi A; Petrone AM; Li Santi A; Alfieri M; Montuori N; Ragno P
    Cells; 2020 Nov; 9(12):. PubMed ID: 33255171
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.